RS2881654 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Albumin (maximum, inv-norm transformed) | G | β: 0.049 | 2E-39 | PubMed |
| Anterior thigh muscle fat infiltration percentage | A | OR: 9.66 | 4E-22 | PubMed |
| Triglyceride levels (UKB data field 30870) | A | β: 0.025 | 6E-20 | PubMed |
| Concentration of chylomicrons and extremely large VLDL particles | A | β: 0.02 | 3E-17 | PubMed |
| Phospholipid levels in chylomicrons and extremely large VLDL | A | β: 0.02 | 2E-16 | PubMed |
| Triglyceride levels in chylomicrons and extremely large VLDL | A | β: 0.02 | 3E-16 | PubMed |
| Concentration of very large VLDL particles | A | β: 0.02 | 5E-16 | PubMed |
| Body fat percentage and type 2 diabetes (pairwise) | A | — | 8E-16 | PubMed |
| Total lipid levels in chylomicrons and extremely large VLDL | A | β: 0.02 | 1E-15 | PubMed |
| Total lipids in large VLDL | A | β: 0.02 | 3E-14 | PubMed |
| Concentration of large VLDL particles | A | β: 0.02 | 3E-14 | PubMed |
| Free cholesterol levels in chylomicrons and extremely large VLDL | A | β: 0.02 | 6E-14 | PubMed |
| Body mass index and type 2 diabetes (pairwise) | A | — | 9E-14 | PubMed |
| Phospholipids in very large VLDL | A | β: 0.02 | 2E-13 | PubMed |
| Cholesterol levels in chylomicrons and extremely large VLDL | A | β: 0.02 | 2E-13 | PubMed |
| Type 2 diabetes with neurological manifestations (PheCode 250.24) | G | β: 0.059 | 1E-12 | PubMed |
| Cholesteryl ester levels in chylomicrons and extremely large VLDL | A | β: 0.02 | 2E-12 | PubMed |
| Waist-hip ratio and type 2 diabetes (pairwise) | A | — | 9E-12 | PubMed |
| Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | A | β: 0.02 | 9E-12 | PubMed |
| Free cholesterol in very large VLDL | A | β: 0.02 | 1E-11 | PubMed |